Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

by Monica Gerson, Benzinga Staff Writer

August 7, 2014 4:24 AM | 1 min read | Make a Comment

Below are the biotechnology stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Amgen

AMGN

is $19.46 billion. Amgen's profit margin for the same period is 25.74%. The trailing-twelve-month revenue at Gilead Sciences

GILD

is $17.44 billion. Gilead Sciences' ROE for the same period is 53.55%. The trailing-twelve-month revenue at Biogen Idec

BIIB

is $8.34 billion. Biogen Idec's EPS for the same period is $8.04. The trailing-twelve-month revenue at Celgene

CELG

is $7.03 billion. Celgene's PEG ratio is 0.89.

Posted In: Trading Ideas Biotechnology Industry revenue

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.